IFNA1 and hairy cell leukemia: The study aims to evaluate the efficacy of treatment with cladribine and IFN in a group of 11 patients with hairy cell leukemia hospitalized at the Clinic of Hematology and Oncology, Kermanshah, Iran, over a period of 15 years.